Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-26-124063·Braveheart Bio, Inc.
Schedule 13G ownership disclosure
Braveheart Bio Inc
Common Stock, par value $0.0001 per share · CUSIP: 10567X101
Event date: 2026-09-30
- Filing-level shares
- 7,420,091.00
- Percent of class
- 8.2%
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Shares: 7,420,091.00 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-124063
- Form type
- SCHEDULE 13G
- Filer
- Braveheart Bio, Inc.
- CIK
- CIK 2131524
- Filed
- Nov 09, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership